Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : LEGN save search
Legend Biotech to Host Investor Conference Call on First Quarter 2024 Results
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
LEGN | $46.14 -2.08% -2.12% 1.2M
|
Health Technology
|
| O: 0.02%
H: 0.22%
C: -0.88%
first conference biotech results
Legend Biotech Announces Publication of Inaugural Environmental, Social and Governance (ESG) Report
Published: 2024-03-19 (Crawled : 14:00) - biospace.com/
LEGN | $46.14 -2.08% -2.12% 1.2M
|
Health Technology
|
| O: -1.56%
H: 0.99%
C: -1.3%
report biotech publication
CARVYKTI® (ciltacabtagene autoleucel) Receives Recommendation from the U.S. FDA Oncologic Drugs Advisory Committee for Earlier Treatment of Patients with Relapsed/Refractory Multiple Myeloma
Published: 2024-03-15 (Crawled : 21:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.58%
H: 0.0%
C: 0.0%
LEGN | $46.14 -2.08% -2.12% 1.2M
|
Health Technology
|
| O: -0.27%
H: 4.91%
C: -2.9%
carvykti fda treatment
Legend Biotech Reports Fourth Quarter and Full Year 2023 Results and Recent Highlights
Published: 2024-03-11 (Crawled : 12:30) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.43%
H: 0.0%
C: 0.0%
LEGN | $46.14 -2.08% -2.12% 1.2M
|
Health Technology
|
| O: 1.08%
H: 3.77%
C: 1.97%
biotech year results
Legend Biotech Announces Positive CHMP Opinion for CARVYKTI® (ciltacabtagene autoleucel) for the Treatment of Patients with Relapsed and Lenalidomide Refractory Multiple Myeloma in Earlier Lines of Therapy
Published: 2024-02-23 (Crawled : 22:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: 0.0%
LEGN | $46.14 -2.08% -2.12% 1.2M
|
Health Technology
|
| O: 2.07%
H: 5.02%
C: 4.92%
carvykti chmp biotech positive treatment therapy
Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2023 Results
Published: 2024-02-13 (Crawled : 13:30) - biospace.com/
LEGN | $46.14 -2.08% -2.12% 1.2M
|
Health Technology
|
| O: -1.6%
H: 1.8%
C: -1.41%
conference biotech year results
Legend Biotech to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-02 (Crawled : 20:00) - biospace.com/
LEGN | $46.14 -2.08% -2.12% 1.2M
|
Health Technology
|
| O: -1.18%
H: 2.49%
C: -0.61%
conference biotech
Patient-Reported Outcomes from the CARTITUDE-4 Study Showed Clinically Meaningful Improvements in Health-Related Quality of Life and Reductions in Multiple Myeloma Symptoms Following Treatment with CARVYKTI® (ciltacabtagene autoleucel)
Published: 2023-12-12 (Crawled : 08:00) - biospace.com/
LEGN | $46.14 -2.08% -2.12% 1.2M
|
Health Technology
|
| O: 0.78%
H: 3.23%
C: 2.76%
carvykti life treatment study
Legend Biotech Announces Exclusive, Global License Agreement for Certain CAR-T Therapies Targeting DLL3
Published: 2023-11-13 (Crawled : 14:30) - biospace.com/
LEGN | $46.14 -2.08% -2.12% 1.2M
|
Health Technology
|
| O: 5.54%
H: 0.0%
C: -4.94%
biotech license global car-t agreement
Legend Biotech to Host Investor Conference Call on Third-Quarter Results
Published: 2023-11-07 (Crawled : 14:00) - biospace.com/
LEGN | $46.14 -2.08% -2.12% 1.2M
|
Health Technology
|
| O: 0.42%
H: 1.62%
C: 0.48%
conference biotech results
Legend Biotech to Showcase Leadership in Multiple Myeloma Treatment at the ASH 2023 Annual Meeting
Published: 2023-11-02 (Crawled : 15:00) - biospace.com/
LEGN | $46.14 -2.08% -2.12% 1.2M
|
Health Technology
|
| O: 0.52%
H: 0.28%
C: -3.54%
biotech treatment meeting
Legend Biotech Reports Second Quarter 2023 Results and Recent Highlights
Published: 2023-08-15 (Crawled : 11:00) - biospace.com/
LEGN | $46.14 -2.08% -2.12% 1.2M
|
Health Technology
|
| O: -8.81%
H: 7.25%
C: 4.36%
biotech results
Legend Biotech to Host Investor Conference Call on Second-Quarter Results
Published: 2023-08-03 (Crawled : 14:00) - biospace.com/
LEGN | $46.14 -2.08% -2.12% 1.2M
|
Health Technology
|
| O: -0.32%
H: 0.64%
C: -0.33%
conference biotech results
Promising Developments Announced Ahead of 2023 ASCO Annual Meeting's Oral Presentations
Published: 2023-05-26 (Crawled : 15:00) - prnewswire.com
DAWN 4 | $14.98 -4.89% -5.14% 1.4M
|
Professional, Scientific, and T...
|
| O: 0.33%
H: 4.21%
C: 3.06%
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -0.93%
H: 0.0%
C: -18.22%
LEGN | $46.14 -2.08% -2.12% 1.2M
|
Health Technology
|
| O: 0.35%
H: 0.63%
C: -0.58%
IMGN | $31.23 0.03% 49M
|
Health Technology
|
| O: 0.07%
H: 2.53%
C: 1.23%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.45%
H: 0.79%
C: -1.17%
asco
Legend Biotech Announces Submission to the European Medicines Agency for Expanded Use of CARVYKTI® (ciltacabtagene autoleucel)
Published: 2023-05-25 (Crawled : 20:00) - biospace.com/
LEGN | $46.14 -2.08% -2.12% 1.2M
|
Health Technology
|
| O: -1.45%
H: 0.0%
C: -2.77%
carvykti biotech submission
Legend Biotech Reports First Quarter 2023 Results and Recent Highlights
Published: 2023-05-18 (Crawled : 13:00) - biospace.com/
LEGN | $46.14 -2.08% -2.12% 1.2M
|
Health Technology
|
| O: -1.22%
H: 1.18%
C: -2.19%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: -0.13%
H: 0.12%
C: -0.13%
biotech results
Legend Biotech to Demonstrate Progress in Advancing Potential Treatment Options for Patients with Multiple Myeloma at ASCO and EHA Annual Meetings
Published: 2023-05-16 (Crawled : 13:20) - biospace.com/
LEGN | $46.14 -2.08% -2.12% 1.2M
|
Health Technology
|
| O: -0.49%
H: 0.14%
C: -0.04%
biotech asco treatment potential
Legend Biotech Corporation Announces Pricing of Registered Direct Offering of $350 Million of American Depositary Shares
Published: 2023-05-08 (Crawled : 13:00) - biospace.com/
LEGN | $46.14 -2.08% -2.12% 1.2M
|
Health Technology
|
| O: -2.42%
H: 5.43%
C: 5.16%
biotech corporation direct offering
Legend Biotech Announces Appointment of Chief Medical Officer
Published: 2023-04-11 (Crawled : 14:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.21%
H: 0.28%
C: -1.01%
LEGN | $46.14 -2.08% -2.12% 1.2M
|
Health Technology
|
| O: 0.88%
H: 2.35%
C: 0.68%
biotech medical
Legend Biotech Reports Full-Year 2022 Results and Recent Highlights
Published: 2023-03-30 (Crawled : 00:00) - biospace.com/
LEGN | $46.14 -2.08% -2.12% 1.2M
|
Health Technology
|
| O: 0.46%
H: 1.08%
C: -0.74%
biotech results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.